Applications of ATAC-seq

Assay for Transposase-Accessible Chromatin using sequencing (ATAC-seq) is a powerful technique in epigenomics, allowing researchers to study chromatin accessibility. ATAC-seq has broad applications in biomedical research, ranging from disease pathogenesis to drug discovery, and it plays a key role in understanding cellular differentiation at single-cell resolution. Below is a detailed exploration of the applications of ATAC-seq in various fields.

Number of ATAC-seq-related articles with different classifications¹ (Zhao, Y. et al,2020)

ATAC-seq in Epigenetics and Disease Research 

Chromatin accessibility is crucial for gene regulation, and changes in chromatin structure are often linked to diseases. ATAC-seq helps reveal which regions of the genome are open and available for transcription, providing valuable insights into how epigenetic mechanisms contribute to health and disease².

In complex diseases such as cardiovascular disorders or diabetes, ATAC-seq can identify open chromatin regions associated with specific gene regulation changes, offering clues to genetic susceptibility. For example, Davidson, R. K. et al used ATAC-seq to identify chromatin regions associated with insulin regulation, linking them to gene expression changes that impact diabetes-related β-cell function³. Additionally, it helps track epigenetic markers associated with environmental exposures or lifestyle factors, giving researchers the ability to study interactions between genetics and environment on a molecular level.

ATAC-seq also complements other sequencing methods, such as ChIP-seq, by offering a broader view of regulatory regions, including promoters and enhancers. These data help build models for gene expression regulation, especially in understanding the dynamic changes in chromatin landscapes under various conditions.

Applications in Cancer, Neurological Disorders, and Autoimmune Diseases

Chromatin remodeling plays a critical role in cancer development, neurological disorders, and autoimmune diseases. ATAC-seq is particularly useful in identifying mutations and abnormal regulatory elements associated with these diseases.

Cancer Research with ATAC-seq

Cancer is driven not only by genetic mutations but also by epigenetic alterations, which influence gene expression patterns and cellular behavior. ATAC-seq provides an effective approach for studying these epigenetic modifications by mapping accessible chromatin regions across different cancer types and stages⁴. It helps researchers discover aberrant enhancer and promoter activities responsible for oncogene activation and tumor suppressor silencing.

ATAC-seq plays several key roles in cancer research:  

• Identifying Regulatory Mutations:

ATAC-seq is crucial in pinpointing non-coding mutations that impact chromatin accessibility, which can lead to tumor progression. For instance, in a large-scale study using ATAC-seq data from 410 tumor samples, researchers identified over 562,709 transposase-accessible DNA elements, including distal enhancers that are linked to cancer progression through chromatin accessibility changes⁵.

• Tumor Heterogeneity:

Single-cell ATAC-seq (scATAC-seq) helps dissect tumor heterogeneity, revealing distinct subpopulations of cancer cells. In acute lymphoblastic leukemia (ALL), scATAC-seq has been used to uncover chromatin accessibility differences between subclones, which allows for better understanding of how different populations within the same tumor contribute to treatment response and progression⁶.

• Tracking Treatment Resistance:

ATAC-seq plays a role in studying how cancer cells acquire resistance to therapies. For example, it was shown that chromatin regulators contribute to drug resistance by altering transcription factor binding in resistant cells, which can be tracked by comparing ATAC-seq profiles before and after treatment. These findings enable the development of combination therapies aimed at overcoming resistance⁷.

• Immuno-Oncology Applications:

ATAC-seq helps profile the immune cells within the tumor microenvironment. By identifying changes in regulatory elements of immune cells, such as T-cells, ATAC-seq provides insights into how the immune system interacts with tumors, which is essential for developing immune checkpoint inhibitors. A recent study linked transcription factor activity in immune cells to specific immune responses within tumors⁸.

Neurological Disorders

Neurodevelopmental and neurodegenerative diseases often involve complex interactions between genetics and the epigenome. ATAC-seq allows for the investigation of how chromatin accessibility changes contribute to conditions such as autism spectrum disorders (ASD), schizophrenia, and Alzheimer's disease.

Here are specific examples for each point regarding the use of ATAC-seq in neurodevelopmental and neurodegenerative diseases:

• Neurodevelopmental Disorders (e.g., Autism Spectrum Disorders - ASD):

ATAC-seq has been applied to study chromatin accessibility during brain development, helping to uncover mutations in regulatory elements. For instance, a study on *Activity-Dependent Neuroprotective Protein (ADNP)* identified chromatin remodeling as a key factor in the development of ASD, revealing how mutations in ADNP affect neural tube formation and synaptic development, predisposing individuals to ASD⁹.

• Schizophrenia and Bipolar Disorder:

In schizophrenia, ATAC-seq has been utilized to investigate chromatin accessibility differences in neurons and glial cells. One study revealed that regions associated with schizophrenia exhibited significant differences in chromatin accessibility when compared to healthy controls, providing insights into disease-associated regulatory elements and the disrupted gene networks involved in psychiatric conditions¹⁰.

• Neurodegenerative Diseases (e.g., Alzheimer's Disease):

ATAC-seq has provided valuable data on chromatin changes in postmortem brain tissues from patients with Alzheimer's disease. Researchers have identified epigenetic signatures related to synaptic plasticity, inflammation, and protein aggregation, which are crucial in the pathology of Alzheimer's. For example, single-cell transcriptomics combined with ATAC-seq helped identify cell-type-specific changes in chromatin accessibility, advancing our understanding of how Alzheimer's progresses at the molecular level¹⁰.

The ability of ATAC-seq to uncover epigenetic changes in brain tissue enables new avenues for therapeutic development, including gene therapies and epigenetic drugs. Additionally, scATAC-seq is valuable for studying cell-type-specific chromatin dynamics in mixed populations of neurons, astrocytes, and microglia, which are often implicated in neuroinflammation and neurodegeneration.

Autoimmune Diseases and Inflammation

In autoimmune diseases, the immune system mistakenly attacks healthy tissues, often driven by dysregulation in immune cell gene expression. ATAC-seq helps identify how chromatin changes in immune cells contribute to autoimmune responses, offering new insights into the molecular mechanisms underlying these disorders¹¹.

• T Cell and B Cell Regulation:

ATAC-seq has revealed significant chromatin accessibility changes in T and B cells, particularly in autoimmune diseases like systemic lupus erythematosus (SLE). One study showed that in SLE, B cells exhibited altered chromatin landscapes that regulated cytokine expression, such as IL-6 and TNF-α, contributing to the abnormal activation of immune cells¹².

• Biomarker Discovery:

In diseases like rheumatoid arthritis (RA) and multiple sclerosis (MS), ATAC-seq has identified specific epigenetic biomarkers in immune cells, such as B and T cells. These biomarkers are predictive of disease onset and progression. Additionally, they are useful in tracking the effectiveness of treatments over time, helping in therapeutic monitoring¹³.

• Epigenetic Mechanisms in Inflammatory Pathways:

ATAC-seq has helped map regulatory elements such as enhancers and promoters controlling inflammatory genes like IL-8, IL-6, and TNF-α. These elements are frequently dysregulated in autoimmune conditions like RA and lupus, driving chronic inflammation¹². Understanding these epigenetic alterations provides insights into the mechanisms that underlie persistent immune activation.

ATAC-seq has become a key tool in identifying therapeutic targets in autoimmune diseases. Drugs targeting epigenetic enzymes, such as histone deacetylase inhibitors (HDAC inhibitors), are under investigation for modulating chromatin states and suppressing aberrant immune responses. ATAC-seq also assists in repurposing existing drugs by identifying shared regulatory elements between different autoimmune diseases, guiding the development of broad-spectrum treatments.

Use of ATAC-seq in Drug Discovery and Development

ATAC-seq is increasingly employed in drug discovery to identify epigenetic targets and evaluate drug efficacy. The chromatin landscape provides essential information about the state of gene expression in different conditions, offering insight into how potential drugs might alter gene activity.

In preclinical drug testing, ATAC-seq can determine how compounds affect chromatin accessibility across various tissues, helping to predict side effects or off-target effects. For example:

• Cancer therapies: It evaluates the impact of epigenetic drugs on tumor cells.
• Neurological treatments: ATAC-seq measures how drugs targeting the nervous system alter chromatin states in neuronal cells.

Furthermore, ATAC-seq is useful in drug repurposing efforts by comparing the chromatin accessibility profiles induced by different drugs, identifying new applications for existing drugs¹⁴.

ATAC-seq in Developmental Biology and Cellular Differentiation

ATAC-seq plays a crucial role in studying the dynamics of chromatin accessibility during development. In embryogenesis, tissues undergo multiple stages of differentiation, with each stage marked by changes in chromatin accessibility. ATAC-seq enables researchers to:

• Monitoring the sequential opening and closing of chromatin regions during development:

ATAC-seq has been used to study how chromatin accessibility changes during different stages of embryogenesis. For example, studies using ATAC-seq have shown how chromatin regions open and close in a regulated sequence to control gene expression during the development of tissues like the neural crest and mesoderm in vertebrates¹⁵.

• Identifying master regulators and transcription factors driving cellular differentiation:

ATAC-seq helps in identifying master regulators and transcription factors that guide cellular differentiation. In neural progenitor cells (NPCs), for instance, ATAC-seq identified key transcription factors that control the differentiation process, which could be linked to broader developmental pathways in embryogenesis.

• Understanding differences in chromatin accessibility between healthy and diseased development (e.g., congenital disorders):

ATAC-seq is used to investigate how chromatin accessibility patterns differ in healthy and diseased development, particularly in congenital disorders. For instance, in congenital heart diseases, ATAC-seq has been applied to reveal how accessibility changes in regulatory regions may lead to developmental anomalies in the heart.

The technique has also shed light on reprogramming processes, such as the conversion of somatic cells to induced pluripotent stem cells (iPSCs)¹⁶. ATAC-seq provides insights into how the epigenetic landscape changes during reprogramming and how it affects the maintenance of stem cell identity.

Single-Cell ATAC-seq for Investigating Cellular Heterogeneity 

Single-cell ATAC-seq (scATAC-seq) offers a groundbreaking approach to exploring the diversity and complexity of chromatin accessibility at the individual cell level. It plays a crucial role in understanding cellular heterogeneity, a fundamental feature of many biological processes and disease states¹⁷. Unlike bulk ATAC-seq, which provides an average chromatin accessibility profile for a population of cells, scATAC-seq resolves these profiles for individual cells, revealing subtle differences that contribute to tissue function, development, and disease.

Uncovering Cellular Diversity and States

In tissues with complex cellular composition, such as the brain, immune system, or tumors, scATAC-seq is essential for identifying previously uncharacterized cell types and subpopulations. For instance:

• Brain Research: scATAC-seq has been used to identify rare neuronal and glial subtypes, providing insights into how chromatin dynamics influence cognitive functions, behavior, and neurological diseases. For example, a study identified an invasive cancer stem cell population associated with lower survival in glioblastoma using single-cell chromatin accessibility profiling. This research helps in understanding how chromatin dynamics influence cognitive functions and neurological diseases¹⁸.
• Immune Cell Profiling: In immunology, it helps delineate distinct T cell, B cell, and innate immune cell states. This information is crucial for understanding immune responses in infection, vaccination, and autoimmunity. For instance, A study used scATAC-seq to interpret T cell states from single-cell transcriptomics data using reference atlases, which is crucial for understanding immune responses in infection, vaccination, and autoimmunity¹⁹.
• Cancer Studies: scATAC-seq resolves tumor heterogeneity by identifying different cancer cell clones with unique chromatin states, many of which exhibit varied responses to therapy.

This level of resolution allows researchers to study cell states more precisely, including dynamic transitions such as those occurring during differentiation, proliferation, or stress responses.

Mapping Cellular Trajectories and Developmental Lineages

One of the powerful applications of scATAC-seq is the reconstruction of lineage trajectories. By tracking changes in chromatin accessibility, researchers can infer how stem cells and progenitors transition into mature cell types. For example:

• Developmental Biology: scATAC-seq reveals the sequence of chromatin changes guiding cell fate decisions in embryonic development, providing insights into the regulation of differentiation.
• Hematopoiesis: In blood cell formation, it maps the trajectory from hematopoietic stem cells to mature immune cells, highlighting how different accessibility patterns drive specific lineages.

These trajectory analyses offer valuable insights into the regulatory landscapes governing tissue development, regeneration, and repair.

Understanding Disease Mechanisms at the Single-Cell Level

scATAC-seq is instrumental in revealing disease-associated epigenetic changes within specific cell populations. This is particularly relevant in diseases with a heterogeneous cellular landscape, such as cancer and autoimmune disorders.

• Cancer Progression: scATAC-seq enables the identification of epigenetically distinct subclones that promote tumor growth or resist treatment. Researchers used scATAC-seq to analyze patient-matched primary-recurrent paired specimens of glioblastoma. The study identified distinct cell populations and their responses to therapy, which could inform the development of targeted treatments²⁰. These findings inform the development of targeted therapies aimed at specific cell populations.
• Neurodegenerative Diseases: It sheds light on how chromatin changes within neurons or glial cells contribute to diseases like Alzheimer's and Parkinson's, helping to uncover epigenetic biomarkers and therapeutic targets. For example, research leveraging single-cell ATAC-seq and RNA-seq aimed to identify disease-critical fetal and adult brain cell types, which could contribute to understanding the epigenetic changes in neurodegenerative diseases like Alzheimer's and Parkinson's²¹.
• Autoimmune Diseases: In conditions like multiple sclerosis and lupus, scATAC-seq reveals immune cell heterogeneity and the chromatin accessibility patterns that drive aberrant immune responses. One study discusses the use of scATAC-seq in understanding immune cell heterogeneity in conditions like multiple sclerosis and lupus, which is crucial for identifying the chromatin accessibility patterns driving aberrant immune responses²².

Integration with Multi-Omics Approaches

scATAC-seq data is often integrated with other single-cell omics methods, such as single-cell RNA-seq (scRNA-seq), to correlate chromatin accessibility with gene expression. This multi-omics approach provides a more comprehensive understanding of gene regulation and cell function, uncovering the relationships between chromatin landscapes, transcriptional profiles, and phenotypic diversity.

References

1. Zhao, Y. et al. Bibliometric Analysis of ATAC-Seq and Its Use in Cancer Biology via Nucleic Acid Detection. Front. Med. 7, (2020).
2. Tsompana, M. & Buck, M. J. Chromatin accessibility: a window into the genome. Epigenetics & Chromatin 7, 33 (2014).
3. Davidson, R. K. et al. The Chd4 Helicase Regulates Chromatin Accessibility and Gene Expression Critical for β-Cell Function In Vivo. Diabetes 72, 746–757 (2023).
4. Hu, Y. et al. Single-cell sequencing technology applied to epigenetics for the study of tumor heterogeneity. Clinical Epigenetics 15, 161 (2023).
5. Corces, M. R. et al. The chromatin accessibility landscape of primary human cancers. Science 362, eaav1898 (2018).
6. Malyukova, A. et al. Sequential drug treatment targeting cell cycle and cell fate regulatory programs blocks non-genetic cancer evolution in acute lymphoblastic leukemia. Genome Biology 25, 143 (2024).
7. Wajapeyee, N. & Gupta, R. Epigenetic Alterations and Mechanisms That Drive Resistance to Targeted Cancer Therapies. Cancer Research 81, 5589–5595 (2021).
8. Yu, Z. et al. Integrative Single-Cell Analysis Reveals Transcriptional and Epigenetic Regulatory Features of Clear Cell Renal Cell Carcinoma. Cancer Research 83, 700–719 (2023).
9. D'Incal, C. P. et al. Chromatin remodeler Activity-Dependent Neuroprotective Protein (ADNP) contributes to syndromic autism. Clinical Epigenetics 15, 45 (2023).
10. Luquez, T. et al. Cell type-specific changes identified by single-cell transcriptomics in Alzheimer's disease. Genome Medicine 14, 136 (2022).
11. Qiu, Y. et al. 3D genome organization and epigenetic regulation in autoimmune diseases. Front. Immunol. 14, (2023).
12. de Gruijter, N. M., Jebson, B. & Rosser, E. C. Cytokine production by human B cells: role in health and autoimmune disease. Clinical and Experimental Immunology 210, 253–262 (2022).
13. Musette, P. & Bouaziz, J. D. B Cell Modulation Strategies in Autoimmune Diseases: New Concepts. Front. Immunol. 9, (2018).
14. Zhang, H. et al. txci-ATAC-seq: a massive-scale single-cell technique to profile chromatin accessibility. Genome Biology 25, 78 (2024).
15. Buenrostro, J. D., Wu, B., Chang, H. Y. & Greenleaf, W. J. ATAC‐seq: A Method for Assaying Chromatin Accessibility Genome‐Wide. CP Molecular Biology 109, (2015).
16. A way to wipe a cell's memory. Nature (2023) doi:10.1038/d41586-023-02381-3.
17. Booth, G. T. et al. High-capacity sample multiplexing for single cell chromatin accessibility profiling. BMC Genomics 24, 737 (2023).
18. Guilhamon, P. et al. Single-cell chromatin accessibility profiling of glioblastoma identifies an invasive cancer stem cell population associated with lower survival. eLife 10, e64090 (2021).
19. Andreatta, M. et al. Interpretation of T cell states from single-cell transcriptomics data using reference atlases. Nat Commun 12, 2965 (2021).
20. Wang, L. et al. A single-cell atlas of glioblastoma evolution under therapy reveals cell-intrinsic and cell-extrinsic therapeutic targets. Nat Cancer 3, 1534–1552 (2022).
21. Kim, S. S. et al. Leveraging single-cell ATAC-seq and RNA-seq to identify disease-critical fetal and adult brain cell types. Nat Commun 15, 563 (2024).
22. Rachid Zaim, S. et al. MOCHA's advanced statistical modeling of scATAC-seq data enables functional genomic inference in large human cohorts. Nat Commun 15, 6828 (2024).